Want to join the conversation?
$NKE expects the full year 2017 gross margin rate to contract. For 2Q17, gross margin is expected to contract by approx. 125 BPs with the rate in 2H17 approaching flat versus the prior year. For total SG&A, the company expects full year growth in the mid to high single digits with 2Q17 growing in the low to mid-single-digit range.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?